Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-06-14 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
关于收购控股子公司少数股东股权的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the acquisition of minority shareholders' equity in a subsidiary company by Shenzhen Huitai Medical Device Co., Ltd. It includes extensive information about the transaction overview, parties involved, financial data, valuation reports, pricing, payment arrangements, and legal terms. The content focuses on a capital transaction involving the purchase of shares in a subsidiary, with no indication of it being a full financial report, earnings release, or management discussion. It is not a merger or acquisition filing in the sense of a merger proxy or tender offer, but rather a capital/financing update about a share acquisition. The document is lengthy (15,000 characters) and contains substantive details about the financing and capital structure change due to the acquisition. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-06-14 Chinese
关于增加公司2022年度日常关联交易预计额度的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the increase of the company's 2022 annual expected daily related-party transaction amount. It details the approval process by the board and supervisory committee, the nature and amounts of related-party transactions, and includes independent directors' opinions and sponsor institution's verification. It is a regulatory announcement about a specific corporate action (increase in related-party transaction limits) that requires shareholder approval. It does not contain financial statements or detailed financial results, nor is it a report or transcript. It is not a voting result announcement but a corporate disclosure about related-party transactions. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-06-14 Chinese
关于以集中竞价交易方式回购股份方案的公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement from Shenzhen Huitai Medical Equipment Co., Ltd. regarding a share repurchase plan through centralized bidding transactions. It includes specifics about the purpose of the repurchase, the amount and price limits, the timeline, funding sources, board approval, risk factors, and the intended use of repurchased shares for employee stock ownership plans or equity incentives. The document also discusses the impact on the company's financials and governance, and includes independent directors' opinions and authorization details. There is no indication that this is a full financial report, earnings release, or regulatory certification. The content clearly relates to the company's buyback of its own shares, which fits the definition of a Transaction in Own Shares (POS). The document length and detail confirm it is the announcement of the transaction itself, not a brief notice or a report publication announcement.
2022-06-14 Chinese
关于公司控股股东、实际控制人、董事长兼总经理提议回购公司股份的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Equipment Co., Ltd. regarding a proposal by the controlling shareholder and chairman to repurchase company shares. It details the proposal's background, purpose, specifics of the share repurchase plan, and the board's approval of the proposal. The document does not contain financial statements or results but is an update on a capital action (share repurchase). This fits the category of a company announcement about share repurchase activities, which corresponds to the 'Transaction in Own Shares' category (POS). The document length is 2157 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is POS with high confidence.
2022-06-14 Chinese
第一届监事会第十七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shenzhen Huitai Medical Devices Co., Ltd. It details the approval of several proposals including a share repurchase plan, increase in related party transaction limits, changes in investment projects, and acquisition of minority interests in subsidiaries. The document includes voting results and states that some proposals will be submitted to the shareholders' meeting for approval. It references other announcements published on the Shanghai Stock Exchange website for detailed content. The document length is short (1696 characters) and it primarily serves as an official announcement of board resolutions rather than a full report or detailed financial data. Therefore, it fits best into the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories like capital/financing update or management information, since it is a supervisory board meeting resolution announcement.
2022-06-14 Chinese
独立董事关于第一届董事会第十九次会议相关议案的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors providing prior approval opinions on agenda items for the company's 19th board meeting. It references compliance with listing rules and internal governance documents. The content is about governance and board meeting matters, specifically independent directors' opinions on related party transactions. The document is short (710 characters) and does not contain financial statements or detailed financial data. It is not an annual report, audit report, or earnings release. It is not a call transcript or capital update. It is clearly related to board/management information, specifically independent directors' opinions on board meeting agenda items. Therefore, the best fitting category is Board/Management Information (MANG).
2022-06-14 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.